Pharmadrug

Holding Companies & Conglomerates · Canada · 11-50 Employees

View Company Info for Free

Overview

Headquarters

77 King St W 2905, Toronto, Ontario, M5K...

Revenue

<$5 Million

Stock Symbol

PHRX.CN

Industry

Holding Companies & Conglomerates Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
2
1
1
2
1

About Pharmadrug

PharmaDrug owns 51% of Sairiyo Therapeutics ("Sairiyo"), a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through clinical trials and the associated regulatory approval process in the US and Europe. Sairiyo is currently developing its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious disease and rare cancers. Sairiyo is also conducting R&D in the psychedelics space for the treatment of non-neuropsychiatric conditions. PharmaDrug also owns 100% of SecureDose Synthetics Inc. ("SecureDose"), a pharmaceutical research and development company focused on the development of synthetic formulations of currently existing drugs for potential commercialization and distribution. Our Growth StrategyExplore more
Pharmadrug's Social MediaPopular SearchesPharmaDrug IncSIC Code 67,671NAICS Code 55,551Ticker TSX: PHRX.CNShow more

Pharmadrug Org Chart

RS
Canada flag for contact location.

Chief Executive Officer

PhoneEmail

Is Pharmadrug your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Pharmadrug

Compare insights from companies similar to Pharmadrug, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Pharmadrug

<$5M
11-50
Public
-
-
$6.3M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
-
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
-
MP
Matt PozdrowskiGeneral Manager
<$5M
1-10
Private
-
-
Illustration of an envelope

Company Profile Activity

i

Among all Holding Companies & Conglomerates companies

Low Activity

High Activity

Activity Insights

Pharmadrug is experiencing very low activity levels compared to other companies in the Holding Companies & Conglomerates sector.

What does this means?

Pharmadrug is drawing exceptional interest within the Holding Companies & Conglomerates industry, suggesting notable developments or strong market momentum, learn more about Pharmadrug.

Pharmadrug Tech Stack

A closer look at the technologies used by Pharmadrug

Top Holding Companies & Conglomerates Companies

Frequently Asked Questions Regarding Pharmadrug

What is Pharmadrug's stock symbol?
Pharmadrug's stock symbol is PHRX.CN
What is Pharmadrug's official website?
Pharmadrug's official website is www.pharmadrug.ca
What is Pharmadrug's Revenue?
Pharmadrug's revenue is <$5 Million
What is Pharmadrug's SIC code?
Pharmadrug's SIC: 67,671
What is Pharmadrug's NAICS code?
Pharmadrug's NAICS: 55,551
How many employees does Pharmadrug have?
Pharmadrug has 11-50 employees
What industry does Pharmadrug belong to?
Pharmadrug is in the industry of: Holding Companies & Conglomerates, Business Services, Research & Development
What is Pharmadrug competition?
Pharmadrug top competitors include: Chronicles Cannabis, Your Highness Cannabis, KJ's Best Cannabis, Rural Leaf
What companies has Pharmadrug acquired?
Pharmadrug has acquired the companies: Sairiyo Therapeutics
What technology does Pharmadrug use?
Some of the popular technologies that Pharmadrug uses are: WordPress.org, PHP, Microsoft 365, Google Tag Manager
What does Pharmadrug do?

PharmaDrug owns 51% of Sairiyo Therapeutics ("Sairiyo"), a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through clinical trials and the associated regulatory approval process in the US and Europe. Sairiyo is currently developing its patented reformulation of cepharanthi... ne, a drug that has shown substantial third party validated potential for the treatment of infectious disease and rare cancers. Sairiyo is also conducting R&D in the psychedelics space for the treatment of non-neuropsychiatric conditions. PharmaDrug also owns 100% of SecureDose Synthetics Inc. ("SecureDose"), a pharmaceutical research and development company focused on the development of synthetic formulations of currently existing drugs for potential commercialization and distribution. Our Growth StrategyRead More

What are Pharmadrug social media links?
Pharmadrug Linkedin page Pharmadrug Twitter page
Is Pharmadrug a public company?
Yes, Pharmadrug is a public company and is traded under the symbol PHRX.CN
See more information about Pharmadrug

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.